Investigational Site 013 — Houston, Texas

Investigational Site 013 is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site 013 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Pericarditis, Pericarditis Acute, Recurrent Pericarditis.

Sponsors: Kiniksa Pharmaceuticals International, plc.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site 013?

Investigational Site 013 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site 013 conducted?

Investigational Site 013 has 1 clinical trials on record, with 1 currently active. Their work covers Pericarditis, Pericarditis Acute, Recurrent Pericarditis.

Is Investigational Site 013 accredited by Crixeo Health?

Investigational Site 013 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site 013?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.